MedPath
HSA Approval

CLARIWIN-250 TABLET 250 mg

SIN12036P

CLARIWIN-250 TABLET 250 mg

CLARIWIN-250 TABLET 250 mg

July 30, 2002

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01FA09

clarithromycin

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

Micro Labs Ltd

Active Ingredients

CLARITHROMYCIN

250 mg

Clarithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLARIWIN-250 TABLET 250 mg - HSA Approval | MedPath